Completed PHASE4 INTERVENTIONAL 2-arm NCT01390246

Bupropion for Smoking Cessation During Pregnancy

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Pregnancy Related Tobacco Use Disorder

Interventions Bupropion SR Placebo Smoking Cessation Counseling

Updated 11 times since 2017 Last updated: Jun 5, 2019 Started: Jul 31, 2011 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Pregnancy Related and Tobacco Use Disorder, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 11 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Dec 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 6 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jul 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Jul 2019 [monthly]

Completed PHASE4
Mar 2018 — Jun 2018 [monthly]

Completed PHASE4
Feb 2017 — Mar 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
The University of Texas Medical Branch, Galveston
UConn Health

Data source: The University of Texas Medical Branch, Galveston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Galveston, United States